News tagged with amylin pharmaceuticals

Amylin's long-delayed diabetes drug gets FDA nod

Amylin Pharmaceuticals won approval Friday for its long-delayed diabetes drug Bydureon, a next-generation treatment that requires fewer injections than the company's 7-year old diabetes medicine, Byetta.

Diabetes Jan 28, 2012 | not rated yet | 0